| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
APYX
Apyx Medical
|
Aug 07, 2026 | BUY |
Strong Buy
+562.2% avg upside
11 analysts
|
$7.00
70.77% Upside
|
· | · |
|
BDSX
Biodesix
|
Aug 07, 2026 | BUY |
Strong Buy
+43.2% avg upside
9 analysts
|
$27.00
16.24% Upside
|
+0.0% | · |
|
LFMD
LifeMD
|
Aug 07, 2026 | BUY |
Strong Buy
+192.1% avg upside
14 analysts
|
$9.00
164.02% Upside
|
· | · |
|
EYPT
EyePoint Pharmaceuticals
|
Aug 06, 2026 | BUY |
Strong Buy
+143.9% avg upside
20 analysts
|
$27.00
97.71% Upside
|
+8.3% | · |
|
OCS
Oculis Holding
|
Aug 05, 2026 | BUY |
Strong Buy
+198.8% avg upside
11 analysts
|
$26.00
103.03% Upside
|
+0.0% | · |
|
OCUL
Ocular Therapeutix
|
Aug 04, 2026 | BUY |
Strong Buy
+169.6% avg upside
21 analysts
|
$25.00
178.93% Upside
|
+7.0% | · |
|
TEM
Tempus AI, Inc. Class A
|
Aug 04, 2026 | BUY |
Buy
+27.6% avg upside
21 analysts
|
$56.00
11.57% Upside
|
+10.6% | · |
|
BLCO
Bausch + Lomb Corporation
|
Aug 03, 2026 | BUY |
Buy
+19.7% avg upside
19 analysts
|
$21.00
27.55% Upside
|
-0.7% | · |
|
CDNA
CareDx
|
Jul 31, 2026 | HOLD |
Buy
-12.7% avg upside
17 analysts
|
$46.00
0.38% Downside
|
+6.8% | · |
|
AXGN
AxoGen
|
Jul 30, 2026 | BUY |
Strong Buy
-23.0% avg upside
21 analysts
|
$53.00
17.98% Upside
|
+12.3% | · |
|
SMTI
Sanara MedTech
|
Jul 30, 2026 | HOLD |
Buy
+15.2% avg upside
5 analysts
|
$35.00
3.09% Upside
|
+0.1% | · |
|
GKOS
Glaukos
|
Jul 30, 2026 | BUY |
Strong Buy
-7.1% avg upside
21 analysts
|
$195.00
9.91% Upside
|
+4.9% | · |
|
NPCE
NeuroPace
|
Jul 29, 2026 | BUY |
Strong Buy
+24.5% avg upside
13 analysts
|
$20.00
37.86% Upside
|
+1.9% | · |
|
OPK
Opko Health
|
Jul 28, 2026 | BUY |
Buy
+389.7% avg upside
12 analysts
|
$3.00
119.70% Upside
|
-17.0% | · |
|
BLFS
BioLife Solutions
|
Jul 23, 2026 | HOLD |
Buy
-14.5% avg upside
17 analysts
|
$31.00
9.26% Downside
|
+12.6% | · |
|
DRTS
Alpha Tau Medical Ltd
|
Jul 22, 2026 | BUY |
Strong Buy
+4.2% avg upside
5 analysts
|
$15.00
13.13% Upside
|
-0.1% | · |
|
BLTE
Belite Bio, Inc. ADR
|
Jul 22, 2026 | BUY |
Strong Buy
+11.9% avg upside
10 analysts
|
$200.00
22.08% Upside
|
+3.8% | · |
|
GLSI
Greenwich LifeSciences
|
Jul 21, 2026 | BUY |
Strong Buy
+296.4% avg upside
2 analysts
|
$69.00
379.55% Upside
|
-2.0% | · |
|
ANGO
AngioDynamics
|
Jul 16, 2026 | BUY |
Strong Buy
+14.3% avg upside
9 analysts
|
$19.00
22.46% Upside
|
+6.9% | · |
|
COCH
Envoy Medical
|
Jul 15, 2026 | BUY |
Strong Buy
+851.8% avg upside
5 analysts
|
$2.50
274.79% Upside
|
-5.5% | · |
|
OKYO
OKYO Pharma Limited Sponsored ADR
|
Jul 13, 2026 | BUY |
Strong Buy
+402.8% avg upside
4 analysts
|
$5.00
233.35% Upside
|
-3.9% | · |
|
VANI
Vivani Medical
|
Jul 09, 2026 | BUY |
Strong Buy
+225.6% avg upside
6 analysts
|
$3.50
144.06% Upside
|
-14.7% | · |
|
DE:2SE
Sequana Medical N.V
|
Jul 06, 2026 | HOLD |
Hold
1 analyst
|
— | · | · |
|
RGNX
RegenXBio
|
Jul 01, 2026 | BUY |
Strong Buy
+254.1% avg upside
22 analysts
|
$26.00
149.91% Upside
|
-18.1% | · |
|
ANIX
Anixa Biosciences
|
Jun 12, 2026 | BUY |
Strong Buy
+199.5% avg upside
4 analysts
|
$7.00
103.11% Upside
|
+38.5% | · |
|
PMI
Picard Medical, Inc.
|
Jun 04, 2026 | HOLD |
Hold
1 analyst
|
— | · | · |
|
SGP
SpyGlass Pharma
|
May 29, 2026 | BUY |
Strong Buy
+78.9% avg upside
5 analysts
|
$37.00
51.87% Upside
|
+31.4% | · |
|
BEAT
HeartBeam
|
May 22, 2026 | BUY |
Buy
+640.3% avg upside
14 analysts
|
$2.50
377.58% Upside
|
-43.0% | · |
|
HROW
Harrow Health
|
May 14, 2026 | BUY |
Strong Buy
+34.1% avg upside
12 analysts
|
$70.00
73.03% Upside
|
+31.5% | · |
|
OBIO
Orchestra BioMed Holdings
|
May 14, 2026 | BUY |
Strong Buy
+213.2% avg upside
9 analysts
|
$10.00
136.73% Upside
|
+1.0% | · |
|
DE:FYB
Formycon AG
|
Apr 27, 2026 | BUY |
Strong Buy
+167.5% avg upside
5 analysts
|
$36.00
93.62% Upside
|
+3.7% | · |
|
VVOS
Vivos Therapeutics
|
Apr 17, 2026 | BUY |
Strong Buy
+5697.3% avg upside
4 analysts
|
$2.50
675.89% Upside
|
-66.7% | · |
|
BNGO
BioNano Genomics
|
Apr 13, 2026 | BUY |
Buy
+728.1% avg upside
9 analysts
|
$6.00
439.96% Upside
|
-7.6% | · |
|
LPCN
Lipocine
|
Apr 06, 2026 | HOLD |
Strong Buy
+733.2% avg upside
4 analysts
|
— | +9.8% | · |
|
VNRX
VolitionRX
|
Apr 02, 2026 | BUY |
Strong Buy
+1089.4% avg upside
11 analysts
|
$20.00
2467.36% Upside
|
-77.2% | · |
|
VRAX
Virax Biolabs Group Ltd. Class A
|
Jan 09, 2026 | BUY |
Strong Buy
-64.0% avg upside
1 analyst
|
$1.00
63.96% Downside
|
· | · |
|
VERU
Veru
|
Dec 31, 2025 | HOLD |
Strong Buy
+747.1% avg upside
10 analysts
|
— | +8.9% | · |
|
LEXX
Lexaria Bioscience
|
Dec 26, 2025 | BUY |
Strong Buy
+51.7% avg upside
3 analysts
|
$1.50
72.04% Downside
|
-25.4% | · |
|
BRNS
Barinthus Biotherapeutics
|
Dec 11, 2025 | BUY |
Strong Buy
+610.5% avg upside
5 analysts
|
$4.00
627.24% Upside
|
-16.8% | · |
|
CODX
Co-Diagnostics
|
Nov 24, 2025 | HOLD |
Buy
+1199.4% avg upside
5 analysts
|
— | -84.8% | · |
|
ELDN
Eledon Pharmaceuticals
|
Nov 10, 2025 | BUY |
Strong Buy
+323.1% avg upside
11 analysts
|
$9.00
160.04% Upside
|
+49.8% | · |
|
EDSA
Edesa Biotech
|
Nov 03, 2025 | BUY |
Strong Buy
+110.8% avg upside
6 analysts
|
$5.00
11.49% Downside
|
+193.7% | · |
|
ICCM
Icecure Medical
|
Oct 07, 2025 | BUY |
Strong Buy
+1276.0% avg upside
5 analysts
|
$75.00
2327.22% Upside
|
· | · |
|
KALA
KALA BIO
|
Sep 29, 2025 | HOLD |
Strong Buy
+28402.7% avg upside
9 analysts
|
— | · | · |
|
KPRX
Kiora Pharmaceuticals
|
Sep 02, 2025 | BUY |
Strong Buy
+239.6% avg upside
6 analysts
|
$10.00
281.69% Upside
|
-3.3% | · |
|
SRTS
Sensus Healthcare
|
Aug 12, 2025 | BUY |
Buy
+121.3% avg upside
8 analysts
|
$8.00
167.58% Upside
|
-6.1% | · |
|
QUCY
Quantum Cyber
|
Jul 25, 2025 | HOLD |
Buy
+177.8% avg upside
4 analysts
|
— | -47.1% | · |
|
GRDX
GridAI Technologies
|
Apr 11, 2025 | HOLD |
Strong Buy
+639.0% avg upside
7 analysts
|
— | +78.6% | · |
|
RNLXY
Renalytix
|
Nov 07, 2024 | HOLD |
Strong Buy
+289.2% avg upside
5 analysts
|
— | · | · |
|
MBAI
Check-Cap
|
Sep 06, 2024 | HOLD |
Strong Buy
+491.1% avg upside
5 analysts
|
— | -64.0% | · |
|
PRPH
Prophase Labs
|
Aug 27, 2024 | HOLD |
Sell
2 analysts
|
— | · | · |
|
BNBX
BNB Plus
|
Jun 10, 2024 | BUY |
Strong Buy
+6214.3% avg upside
5 analysts
|
$1.50
1053.04% Upside
|
· | · |
|
GNPX
Genprex
|
May 17, 2024 | BUY |
Strong Buy
+73.9% avg upside
5 analysts
|
$10.00
133.10% Upside
|
· | · |
|
CFOR
CapForce
|
Mar 22, 2024 | HOLD |
Buy
+366.7% avg upside
3 analysts
|
— | -45.9% | · |
|
MOTS
Motus Gi Holdings
|
Mar 14, 2024 | HOLD |
Buy
+49433233.3% avg upside
6 analysts
|
— | · | · |
|
NMRD
Nemaura Medical
|
Jan 08, 2024 | HOLD |
Strong Buy
+374999899.9% avg upside
3 analysts
|
— | · | · |
|
HTGMQ
HTG Molecular Diagnostics
|
Nov 09, 2023 | HOLD |
Strong Buy
+733333233.3% avg upside
6 analysts
|
— | · | · |
|
GB:0G99
Oxurion NV
|
Jun 26, 2023 | HOLD |
Hold
+962.2% avg upside
2 analysts
|
— | · | · |
|
IDXG
Interpace Diagnostics Group
|
Mar 27, 2023 | HOLD |
Strong Buy
+642.9% avg upside
9 analysts
|
— | · | · |
|
BPTH
Bio-Path Holdings
|
Mar 27, 2023 | HOLD |
Strong Buy
+22033.3% avg upside
6 analysts
|
— | · | · |
|
XRAY
DENTSPLY SIRONA
|
Apr 22, 2022 | HOLD |
Buy
+138.0% avg upside
25 analysts
|
$48.00
292.38% Upside
|
+1.9% | · |
|
CELC
Celcuity
|
May 11, 2021 | BUY |
Strong Buy
+34.5% avg upside
16 analysts
|
$30.00
66.89% Downside
|
-77.8% | · |
|
HYPD
Hyperion DeFi
|
Apr 01, 2021 | BUY |
Strong Buy
+209.9% avg upside
8 analysts
|
$8.00
193.58% Upside
|
· | · |
|
WHWK
Whitehawk Therapeutics
|
Mar 15, 2021 | HOLD |
Buy
+162.1% avg upside
14 analysts
|
— | -30.0% | · |
|
CYDY
CytoDyn
|
Mar 09, 2021 | HOLD |
Buy
+704.4% avg upside
2 analysts
|
— | -82.5% | · |
|
OGEN
Oragenics
|
Apr 16, 2020 | HOLD |
Buy
+172.8% avg upside
3 analysts
|
— | · | · |
|
TTOO
T2 Biosystems
|
Nov 21, 2019 | HOLD |
Buy
+1421150.1% avg upside
10 analysts
|
— | · | · |
|
SEELQ
Seelos Therapeutics
|
May 10, 2019 | BUY |
Buy
+46385614.3% avg upside
10 analysts
|
$4.00
3999900.05% Upside
|
· | · |
|
VRDN
Viridian Therapeutics
|
Aug 19, 2016 | BUY |
Strong Buy
+50.3% avg upside
32 analysts
|
$4.00
82.66% Downside
|
+34.0% | · |
|
BIOCQ
Biocept
|
Aug 03, 2016 | BUY |
Strong Buy
+84074900.0% avg upside
7 analysts
|
$2.50
2499899.92% Upside
|
· | · |
|
GALT
Galectin Therapeutics
|
Mar 03, 2016 | BUY |
Strong Buy
+193.6% avg upside
8 analysts
|
$7.00
111.52% Upside
|
+25.9% | · |
|
GLMD
Galmed Pharmaceuticals
|
Mar 02, 2016 | BUY |
Buy
+3989.0% avg upside
13 analysts
|
$21.00
3419.31% Upside
|
· | · |
|
INO
Inovio Pharmaceuticals
|
Feb 17, 2016 | BUY |
Buy
+1202.9% avg upside
19 analysts
|
$17.00
2515.05% Upside
|
· | · |
|
LSTA
Lisata Therapeutics
|
Jan 08, 2016 | HOLD |
Buy
+1120.2% avg upside
11 analysts
|
— | · | · |
|
NSPR
InspireMD
|
Jan 07, 2016 | BUY |
Strong Buy
+415.7% avg upside
8 analysts
|
$4.00
455.46% Upside
|
· | · |
|
LADX
LadRx
|
Jan 23, 2015 | BUY |
Strong Buy
+64445.5% avg upside
5 analysts
|
$12.00
108990.88% Upside
|
· | · |
|
ARCT
Arcturus Therapeutics
|
Nov 17, 2014 | HOLD |
Buy
+302.6% avg upside
36 analysts
|
— | +68.4% | · |
|
ERINQ
Erin Energy
|
Sep 30, 2014 | BUY |
Strong Buy
+899999900.1% avg upside
1 analyst
|
$9.00
899999900.08% Upside
|
· | · |
|
TCOM
Trip.com Group Sponsored ADR
|
Aug 01, 2014 | HOLD |
Strong Buy
+33.8% avg upside
33 analysts
|
$66.00
43.02% Upside
|
+14.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.